TNF-α, IL-6, IL-1β, and HOMA-IR were significantly lower in the semaglutide-treated group, suggesting that semaglutide has a beneficial effect on muscle function by reducing the inflammatory response and insulin resistance [51]. The gene discussed is TNF; the disease is Insulin resistance.